Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes
| Status: | Archived |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | February 2011 |
| End Date: | July 2011 |
A Phase 1 Placebo-Controlled Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Escalating Oral Doses Of PF-04937319 In Adult Patients With Type 2 Diabetes Mellitus (T2DM)
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics
(PK), and pharmacodynamics (PD) of PF-04937319 following multiple (14 days) escalating oral
doses in patients with type 2 diabetes.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials